These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 6437310

  • 1. Comparative cost effectiveness of gentamicin and tobramycin.
    Holloway JJ, Smith CR, Moore RD, Feroli ER, Lietman PS.
    Ann Intern Med; 1984 Dec; 101(6):764-9. PubMed ID: 6437310
    [Abstract] [Full Text] [Related]

  • 2. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
    Matzke GR, Lucarotti RL, Shapiro HS.
    Am J Nephrol; 1983 Dec; 3(1):11-7. PubMed ID: 6340504
    [Abstract] [Full Text] [Related]

  • 3. Comparative toxicity of gentamicin versus tobramycin: a randomized prospective study.
    Fong IW, Fenton RS, Bird R.
    J Antimicrob Chemother; 1981 Jan; 7(1):81-8. PubMed ID: 7204294
    [No Abstract] [Full Text] [Related]

  • 4. Cost effectiveness of gentamicin and tobramycin.
    Singer F.
    Ann Intern Med; 1985 Jun; 102(6):867-8. PubMed ID: 3922271
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Update on drug therapy: IX. Gentamicin and tobramycin nephrotoxicity.
    Darr MS, Elenbaas JK.
    J Am Med Womens Assoc (1972); 1981 Oct; 36(10):310-6. PubMed ID: 7346536
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.
    Lerner AM, Reyes MP, Cone LA, Blair DC, Jansen W, Wright GE, Lorber RR.
    Lancet; 1983 May 21; 1(8334):1123-6. PubMed ID: 6133153
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk factors for nephrotoxicity in patients treated with aminoglycosides.
    Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS.
    Ann Intern Med; 1984 Mar 21; 100(3):352-7. PubMed ID: 6364908
    [Abstract] [Full Text] [Related]

  • 15. Is tobramycin less nephrotoxic than gentamicin?
    Burkle WS.
    Clin Pharm; 1986 Jun 21; 5(6):514-6. PubMed ID: 3522055
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
    Khanderia U.
    Hosp Formul; 1986 Oct 21; 21(10):1049-50, 1055-6. PubMed ID: 10311722
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.